Literature DB >> 18519539

Exacerbation of recurrent depression as a result of treatment with varenicline.

Michael K Popkin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18519539     DOI: 10.1176/appi.ajp.2008.07111735

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  23 in total

Review 1.  Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature.

Authors:  Noah S Philip; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price
Journal:  Psychopharmacology (Berl)       Date:  2010-07-08       Impact factor: 4.530

2.  Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis.

Authors:  Serena Tonstad; Simon Davies; Martina Flammer; Cristina Russ; John Hughes
Journal:  Drug Saf       Date:  2010-04-01       Impact factor: 5.606

Review 3.  Newer antipsychotics and upcoming molecules for schizophrenia.

Authors:  Melvin George; Radhika Amrutheshwar; Ravi Philip Rajkumar; Shivanand Kattimani; Steven Aibor Dkhar
Journal:  Eur J Clin Pharmacol       Date:  2013-04-02       Impact factor: 2.953

Review 4.  Signaling pathways in schizophrenia: emerging targets and therapeutic strategies.

Authors:  Caline S Karam; Jacob S Ballon; Nancy M Bivens; Zachary Freyberg; Ragy R Girgis; José E Lizardi-Ortiz; Sander Markx; Jeffrey A Lieberman; Jonathan A Javitch
Journal:  Trends Pharmacol Sci       Date:  2010-06-25       Impact factor: 14.819

Review 5.  Varenicline for tobacco dependence: panacea or plight?

Authors:  Jill M Williams; Michael B Steinberg; Marc L Steinberg; Kunal K Gandhi; Rajiv Ulpe; Jonathan Foulds
Journal:  Expert Opin Pharmacother       Date:  2011-06-06       Impact factor: 3.889

6.  The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice.

Authors:  Kristin M Wildeboer-Andrud; Karen E Stevens
Journal:  Pharmacol Biochem Behav       Date:  2011-07-07       Impact factor: 3.533

7.  Intermediacy and gene-environment interaction: the example of CHRNA5-A3 region, smoking, nicotine dependence, and lung cancer.

Authors:  Sholom Wacholder; Nilanjan Chatterjee; Neil Caporaso
Journal:  J Natl Cancer Inst       Date:  2008-10-28       Impact factor: 13.506

Review 8.  Chronic obstructive pulmonary disease: an update on diagnosis and management issues in older adults.

Authors:  Shoab A Nazir; Marcia L Erbland
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

9.  Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study.

Authors:  Rachna Kasliwal; Lynda V Wilton; Saad A W Shakir
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

10.  An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts.

Authors:  P Bader; P McDonald; P Selby
Journal:  Tob Control       Date:  2008-10-09       Impact factor: 7.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.